113 related articles for article (PubMed ID: 6948081)
1. Studies on platelet aggregation and antiplatelet therapy in blackfoot disease.
Chen WY; Lee FN; Hsieh BS; Yen TS; Chou JH
Taiwan Yi Xue Hui Za Zhi; 1981 Sep; 80(9):873-83. PubMed ID: 6948081
[No Abstract] [Full Text] [Related]
2. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
3. Increased circulating platelet aggregates and coagulation factors in patients with Blackfoot disease.
Shen MC; Tseng WP; Chen CS
Taiwan Yi Xue Hui Za Zhi; 1983 Jul; 82(7):816-21. PubMed ID: 6579233
[No Abstract] [Full Text] [Related]
4. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
6. Dipyridamole and aspirin in arteriosclerosis obliterans of the lower limbs.
Davì G; Pinto A; Palumbo MG; Gallo V; Mazza A; Strano A
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():271-5. PubMed ID: 3159212
[No Abstract] [Full Text] [Related]
7. [Checking of various hemostatic indices in patients with vascular diseases before and after treatment with inhibitors of platelet adhesiveness].
Patrone F; Armani U; Boy E; Botta G; Boccaccio P
Minerva Cardioangiol; 1975; 23(6-7):379-91. PubMed ID: 1143662
[No Abstract] [Full Text] [Related]
8. The use of platelet inhibitors in migraine.
Ryan RE; Ryan RE
Adv Neurol; 1982; 33():247-52. PubMed ID: 7055003
[No Abstract] [Full Text] [Related]
9. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
Aushri Z; Berginer V; Nathan I; Dvilansky A
Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
[TBL] [Abstract][Full Text] [Related]
10. [Antiaggregant therapy in cerebrovascular insufficiency in the aged].
Fabris F; Pernigotti L
Clin Ter; 1979 Jan; 88(1):21-31. PubMed ID: 35301
[No Abstract] [Full Text] [Related]
11. [Moschcowitz's disease: treatment by platelet anti-aggregating agents].
Marmont A
Nouv Presse Med; 1979 Aug 25-Sep 3; 8(33):2687-8. PubMed ID: 573886
[No Abstract] [Full Text] [Related]
12. [How useful has anti-aggregation therapy proven to be today?].
Francetić I
Lijec Vjesn; 1983; 105(7-8):323-4. PubMed ID: 6633156
[No Abstract] [Full Text] [Related]
13. [Platelet anti-aggregants as a treatment for thrombotic thrombocytopenic purpura. Apropos of a case].
Ortiz Monzó F; Sancho García RA; Filgueira Rubio JS; Jiménez Fernández J; Fernández Basave E
Rev Clin Esp; 1983 May; 169(4):279-81. PubMed ID: 6684782
[No Abstract] [Full Text] [Related]
14. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
[No Abstract] [Full Text] [Related]
15. [The use of platelet aggregation-inhibiting drugs in central vestibular pathology caused by atherosclerotic vascular diseases].
Borasi G; Pallestrini EA; Sperati G
Ann Laringol Otol Rinol Faringol; 1975; 74(6):443-53. PubMed ID: 25036
[No Abstract] [Full Text] [Related]
16. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
17. [Chronic treatment of vascular diseases with indobufen].
Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
[TBL] [Abstract][Full Text] [Related]
18. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation behaviour in patients treated with ticlopidine.
Petronio AS; Evangelisti L; Preti R; Gherarducci G; Balbarini A; Giordani R; Mariani M
Drugs Exp Clin Res; 1987; 13(1):43-50. PubMed ID: 3595443
[TBL] [Abstract][Full Text] [Related]
20. [Studies on fluorescent compounds in drinking water of blackfoot disease endemic areas. 6. A preliminary experimental study on peripheral vasculopathy (author's transl)].
Lu FJ; Ling KH
Taiwan Yi Xue Hui Za Zhi; 1979 Apr; 78(4):314-9. PubMed ID: 288828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
